These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8678190)

  • 21. Worldwide clinical experience with ludiomil.
    Dillier
    Act Nerv Super (Praha); 1982 May; 24(2):40-54. PubMed ID: 7048834
    [No Abstract]   [Full Text] [Related]  

  • 22. Pituitary-adrenocortical hyperfunction and intolerance to fluvoxamine, a selective serotonin uptake inhibitor.
    Brown WA; Arato M; Shrivastava R
    Am J Psychiatry; 1986 Jan; 143(1):88-90. PubMed ID: 3079969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of antidepressant based on the dexamethasone suppression test.
    Fraser AR
    Am J Psychiatry; 1983 Jun; 140(6):786-7. PubMed ID: 6846641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to steroid suppression in major depression resistant to antidepressant therapy.
    Murphy BE; Dhar V; Ghadirian AM; Chouinard G; Keller R
    J Clin Psychopharmacol; 1991 Apr; 11(2):121-6. PubMed ID: 1829098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [When discontinue preventive treatment of recurrent depression?].
    Dalery J; Sermet E
    Encephale; 1995 Feb; 21 Spec No 1():59-61. PubMed ID: 7729359
    [No Abstract]   [Full Text] [Related]  

  • 27. The dexamethasone suppression test and unipolar/bipolar distinctions.
    Zisook S; Janowsky DS; Overall JE; Risch SC
    J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dexamethasone suppression test, poststroke depression, and the validity of DSM-III-based diagnostic criteria.
    Ross ED; Gordon WA; Hibbard M; Egelko S
    Am J Psychiatry; 1986 Sep; 143(9):1200-1. PubMed ID: 3752314
    [No Abstract]   [Full Text] [Related]  

  • 29. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI; Halaris A; Baxter L; Schwarcz G; Thompson M; Hurwicz ML; Hill M; Young M; Daugherty K; Clemens A
    Psychopharmacol Bull; 1985; 21(1):77-80. PubMed ID: 3920706
    [No Abstract]   [Full Text] [Related]  

  • 30. [Correlations between clinico-psychiatric findings and the dexamethasone suppression test in depression].
    Rupprecht R; Barocka A; Pichl J
    Psychiatr Prax; 1988 Jul; 15(4):142-5. PubMed ID: 3406225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DST results in nonpsychotic depressed outpatients.
    Khan A; Johnson F; Avery DH; Cohen S; Scherzo B; Dunner DL
    Am J Psychiatry; 1988 Sep; 145(9):1153-6. PubMed ID: 3046385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age.
    Karemaker R; Kavelaars A; ter Wolbeek M; Tersteeg-Kamperman M; Baerts W; Veen S; Samsom JF; Visser GH; van Bel F; Heijnen CJ
    Pediatrics; 2008 Apr; 121(4):e870-8. PubMed ID: 18381516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age and the dexamethasone suppression test in depression.
    Davis KL; Davis BM; Mathé AA; Mohs RC; Rothpearl AB; Levy MI; Gorman LK; Berger P
    Am J Psychiatry; 1984 Jul; 141(7):872-4. PubMed ID: 6731636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hiccup--a side-effect of pulse therapy.
    Kanwar AJ; Kaur S; Dhar S; Ghosh S
    Dermatology; 1993; 187(4):279. PubMed ID: 8274787
    [No Abstract]   [Full Text] [Related]  

  • 35. The dexamethasone suppression test in children: lack of an association with diagnosis.
    Tyrer SP; Barrett ML; Berney TP; Bhate S; Watson MJ; Fundudis T; Kolvin I
    Br J Psychiatry Suppl; 1991 Jul; (11):41-8. PubMed ID: 1840757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive function and the dexamethasone suppression test in depression.
    Caine ED; Yerevanian BI; Bamford KA
    Am J Psychiatry; 1984 Jan; 141(1):116-8. PubMed ID: 6691427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman.
    Ravaris CL; Sateia MJ; Beroza KW; Noordsy DL; Brinck-Johnsen T
    Arch Gen Psychiatry; 1988 Oct; 45(10):966-7. PubMed ID: 3262333
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment with low doses of tranylcypromine resulted in a disappointing remission rate.
    Nolen WA; van den Broek WW; Birkenhäger TK
    Am J Psychiatry; 2007 Mar; 164(3):524; author reply 524. PubMed ID: 17329480
    [No Abstract]   [Full Text] [Related]  

  • 39. The dexamethasone suppression test as an indication of depression in patients with mental retardation.
    Mattes JA; Amsell L
    Am J Ment Retard; 1993 Nov; 98(3):354-9. PubMed ID: 7904820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desipramine plasma levels and clinical response: evidence for a curvilinear relationship.
    Coryell W; Turner RD; Sherman A
    J Clin Psychopharmacol; 1987 Jun; 7(3):138-42. PubMed ID: 3298326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.